Proceedings of the 2016 China Cancer Immunotherapy Workshop

نویسندگان

  • Bin Xue
  • Jiaqi Xu
  • Wenru Song
  • Zhimin Yang
  • Ke Liu
  • Zihai Li
  • Zihai Li
  • Lieping Chen
  • Edward B. Garon
  • Siwen Hu-Lieskovan
  • Wei Ding
  • Chong-Xian Pan
  • Weijing Sun
  • Yong-Jun Liu
  • Lei Zheng
  • Delong Liu
  • Michel Sadelain
  • Cassian Yee
  • Rongfu Wang
  • Meixia Chen
  • Yao Wang
  • Zhiqiang Wu
  • Hanren Dai
  • Can Luo
  • Yang Liu
  • Chuan Tong
  • Yelei Guo
  • Qingming Yang
  • Weidong Han
  • Lisa H. Butterfield
  • Timothy A. Chan
  • Ruirong Yuan
  • Bo Lu
  • Ke Liu
  • Max Ning
  • Harald Enzmann
  • Heinz Zwierzina
چکیده

A1 Proceedings of 2016 China Cancer Immunotherapy Workshop, Beijing, China Bin Xue, Jiaqi Xu, Wenru Song, Zhimin Yang, Ke Liu and Zihai Li China Center for Food and Drug International Exchange (CCFDIE), Beijing, China; Center for Drug Evaluation (CDE) of the China Food and Drug Administration (CFDA), Beijing, China; Chinese American Hematologist and Oncologist Network (CAHON), New York, NY, USA Correspondence: Bin Xue ([email protected]) – China Center for Food and Drug International Exchange (CCFDIE), Beijing, China; Jiaqi Xu ([email protected]) – Center for Drug Evaluation (CDE) of the China Food and Drug Administration (CFDA), Beijing, China; Wenru Song ([email protected]) – Chinese American Hematologist and Oncologist Network (CAHON), New York, NY, USA; Zihai Li ([email protected]) – Chinese American Hematologist and Oncologist Network (CAHON), New York, NY, USA Journal of Hematology & Oncology 2016, 9(Suppl 1):A1

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer

Understanding how murine models can elucidate the mechanisms underlying antitumor immune responses and advance immune-based drug development is essential to advancing the field of cancer immunotherapy. The Society for Immunotherapy of Cancer (SITC) convened a workshop titled, "Challenges, Insights, and Future Directions for Mouse and Humanized Models in Cancer Immunology and Immunotherapy" as p...

متن کامل

Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop

Radiotherapy (RT) has been a fundamental component of the anti-cancer armamentarium for over a century. Approximately half of all cancer patients are treated with radiotherapy during their disease course. Over the two past decades, there has been a growing body of preclinical evidence supporting the immunomodulatory effects of radiotherapy, particularly when combined with immunotherapy, but onl...

متن کامل

Immunotherapy for Breast Cancer Treatment

Breast cancer, as a heterogeneous disease, includes a wide range of pathological and clinical behaviors. Current treatment protocols, including radiotherapy, chemotherapy, and hormone replacement therapy, are mainly associated with poor response and high rate of recurrence. Therefore, more efforts are needed to develop alternative therapies for this type of cancer. Immunotherapy, as a novel str...

متن کامل

اثر ایمونوتراپی سرطان پروستات بر بیان ژنesp انتروکوکوس فکالیس

Background: Prostate cancer is the most commonly diagnosed malignancy and the second leading cause of cancer deaths among men in the world. Immunotherapy is a new, non-invasive and effective method for the treatment of cancer, but its side effects on the normal flora of bacteria and opportunistic infections not known yet. The aim of this study was to evaluate the effects of immunotherapy on Ent...

متن کامل

Whole Tumor Cell Vaccine Adjuvants: Comparing IL-12 to IL-2 and IL-15

Cancer immunotherapy (passive or active) involves treatments which promote the ability of the immune system to fight tumor cells. Several types of immunotherapeutic agents, such as monoclonal antibodies, immune checkpoint inhibitors, non-specific immunomodulatory agents, and cancer vaccines are currently under intensive investigation in preclinical and clinical trials. Cancer vaccines induce pe...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره 9  شماره 

صفحات  -

تاریخ انتشار 2016